about
Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family membersIdentification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distributionMMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO)The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interactionTrypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissueArticular cartilage and changes in arthritis: matrix degradation.Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorptionGlycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunitiesPathophysiology of osteoarthritis: canonical NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in cartilage degradation and chondrocyte differentiationIdentifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug TargetsOsteoarthritis pathogenesis: a review of molecular mechanismsThe 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognitionDiscovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effectsRoles of microRNA and signaling pathway in osteoarthritis pathogenesisExtracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritisBrevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sitesHydrolysis of triple-helical collagen peptide models by matrix metalloproteinasesStructural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interactionMelanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagenMatrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26Maturational disturbance of chondrocytes in Cbfa1-deficient miceCloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domainFibrillin degradation by matrix metalloproteinases: implications for connective tissue remodellingMembrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinasesActivation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)Equivalence of conventionally-derived and parthenote-derived human embryonic stem cellsEffects of ultrasound on estradiol level, bone mineral density, bone biomechanics and matrix metalloproteinase-13 expression in ovariectomized rabbitsMMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation.Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes.Characterization of a rainbow trout matrix metalloproteinase capable of degrading type I collagen.A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis.The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.Vertebral endplate trauma induces disc cell apoptosis and promotes organ degeneration in vitro.Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites.High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
P2860
Q22001456-CABA7754-75C3-4F6E-99C2-BA4496BD7AF6Q24317893-2C67C41A-DFD7-46A4-B555-287E5D9E572CQ24324139-15CF9B7A-78F9-4A8A-ABC1-015ECDEAE945Q24336413-E642224C-3E1F-4263-ACAE-F402F560948EQ24337189-BECD3446-3F11-4830-92AB-B7E9F1BC6DD0Q24805816-EDA664B2-FD5F-4E42-8FE7-ED9BDD7C2F94Q24816674-5011E47A-BD04-4E9C-B603-6B4FEDE6389DQ26745510-E2F1B957-80AB-43D5-8E04-E5EE36DDE1A2Q26777901-AF6E56AF-5B63-4DF4-A32A-72AC405E1145Q26798033-B874E245-EBF4-479B-B8C0-D221456B32B7Q26822238-32927A69-0E44-41CB-B2AD-F8F034E1961CQ26865318-1BD79DDF-7D61-4879-8E05-E44C8DD8DDF4Q27630877-FBBCDF0F-04B7-4EF9-8278-F84CD0861C71Q27646616-D6D70343-4508-4953-B97C-FE052E574083Q28069429-31718CEE-5700-4B6B-AD84-EF91E05F5655Q28070177-62A8B390-ED04-4674-8827-E980E05DEC1BQ28138661-5C511FF0-6B27-4781-A64D-2AEE2B833466Q28143236-823DD767-2F84-4674-8E60-03A3A3EFAA9BQ28189730-A7AB3869-F6DF-4708-AA76-B0221B07A226Q28208045-DE410290-55FA-447A-ADF9-E3EC81780F72Q28214421-50ABA0C7-9AF7-4FB8-B8A1-098D46585E76Q28214784-1BD87339-9318-4031-967E-4E8107C877B6Q28506259-9367785C-51E2-4C38-88F3-272A141317C4Q28610368-DE12677E-4032-4E5E-BA41-A9A915D23226Q28610876-807C11D0-6100-4CF9-AF2E-E15C3991B5BCQ28611036-81F6D79F-9C26-48E8-9134-6C7FF39CEEADQ28619154-E0736A35-79A9-4C11-A5C4-48550952B791Q28743631-E284F9D9-AC5E-4EAB-A822-E8D1EB2903D9Q30397658-C1535C49-F2CC-4AD4-BBD0-E061B72CA5E1Q30495880-28236A92-33B4-494C-9D7C-46BD725105BEQ30656278-8B68382C-3775-4A7E-9789-8A3C96C25596Q30931885-E12FA4E5-974C-44DE-90F3-A1D1E81ECD42Q30964171-D8CFBBA8-CE04-4DDE-9CAC-83775FA5B747Q33257523-EB02832E-E4D0-4B43-AA8F-62880E870BCDQ33261566-1D831DAB-4E58-4E46-A0ED-961117EEE5C6Q33302267-1311D8D2-215C-4829-B69C-E865DE3615D0Q33311561-5CB8FC1E-CC1E-4E55-AD72-507AB89E46FAQ33325058-919CE118-A581-421C-9341-8F9473CD5DE7Q33326151-88517DC9-537C-4324-9963-6518E2293248Q33359599-00917D6B-7833-4979-A422-8E4D855E3BE5
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Biochemical characterization of human collagenase-3
@ast
Biochemical characterization of human collagenase-3
@en
Biochemical characterization of human collagenase-3
@en-gb
Biochemical characterization of human collagenase-3
@nl
type
label
Biochemical characterization of human collagenase-3
@ast
Biochemical characterization of human collagenase-3
@en
Biochemical characterization of human collagenase-3
@en-gb
Biochemical characterization of human collagenase-3
@nl
prefLabel
Biochemical characterization of human collagenase-3
@ast
Biochemical characterization of human collagenase-3
@en
Biochemical characterization of human collagenase-3
@en-gb
Biochemical characterization of human collagenase-3
@nl
P2093
P2860
P921
P3181
P356
P1476
Biochemical characterization of human collagenase-3
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.271.3.1544
P407
P577
1996-01-01T00:00:00Z